Cell & Gene Therapy

layoffs kick out fire workforce reduction
Biotech

Generation Bio eliminates 40% of staff, including C-suite execs

The layoffs will see Generation Bio’s chief development and medical officers exit the building and extend its runway into the second half of 2027.
Nick Paul Taylor Nov 29, 2023 8:58am
market volatility volatile wall street chart

Volatile day for CAR-T biotechs after FDA reveals safety review

Nov 28, 2023 4:35pm
Rendering of an immune cell

'Special' CAR-T target works in solid tumors, but limits remain

Nov 28, 2023 9:00am
Graphic image of someone cutting off a row of stick figures symbolizing employees

CRISPR Therapeutics laid off staff a week after positive AdComm

Nov 22, 2023 1:36pm
graphic image of the gene sequencing process

Flagship launches first UK biotech Quotient Therapeutics

Nov 21, 2023 6:00am
question unanswered wonder ask

Astellas finds underlying liver issues in gene therapy deaths

Nov 16, 2023 7:12am
More News

Gilead hands Arcellx $285M to expand BCMA cell therapy deal

Nov 15, 2023 10:00am

Selecta fuses with Cartesian in reverse merger

Nov 13, 2023 10:30am

Verve shows base editing works in humans—and sees stock sink

Nov 13, 2023 8:43am

Vor Bio's dual stem cell, ADC shows consistent engraftment

Nov 9, 2023 4:10pm